205 related articles for article (PubMed ID: 37889325)
1. Proposal of a prophylactic photobiomodulation protocol for chemotherapy-induced oral and oropharyngeal mucositis: a randomized clinical trial.
Heimlich FV; de Arruda JAA; Pereira NM; Faria LDS; Abreu LG; Ferreira MVL; Kakehasi FM; Travassos DV; Silva TA; Mesquita RA
Lasers Med Sci; 2023 Oct; 38(1):245. PubMed ID: 37889325
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic photobiomodulation therapy using 660 nm diode laser for oral mucositis in paediatric patients under chemotherapy: 5-year experience from a Brazilian referral service.
Nunes LFM; de Arruda JAA; Souza AF; Silva RCC; Lanza CRM; Kakehasi FM; Mesquita RA; Abreu LG; Travassos DV; Silva TA
Lasers Med Sci; 2020 Oct; 35(8):1857-1866. PubMed ID: 32535807
[TBL] [Abstract][Full Text] [Related]
3. Intraoral versus extraoral photobiomodulation therapy in the prevention of oral mucositis in HSCT patients: a randomized, single-blind, controlled clinical trial.
Ramos-Pinto MB; de Lima Gusmão TP; Schmidt-Filho J; Jaguar GC; Martins MD; Alves FA
Support Care Cancer; 2021 Nov; 29(11):6495-6503. PubMed ID: 33905011
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of cryotherapy associated with laser therapy for decreasing severity of melphalan-induced oral mucositis during hematological stem-cell transplantation: a prospective clinical study.
de Paula Eduardo F; Bezinelli LM; da Graça Lopes RM; Nascimento Sobrinho JJ; Hamerschlak N; Correa L
Hematol Oncol; 2015 Sep; 33(3):152-8. PubMed ID: 24519448
[TBL] [Abstract][Full Text] [Related]
5. Window therapeutic of extraoral photobiomodulation for prevention of oral mucositis in HSCT patients: additional arm.
da Cruz Santos LB; Ramos-Pinto MB; Zerbato RM; Ferreira MEMG; Schmidt-Filho J; Martins MD; Alves FA
Support Care Cancer; 2023 Dec; 32(1):27. PubMed ID: 38097854
[TBL] [Abstract][Full Text] [Related]
6. Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT).
Vitale MC; Modaffari C; Decembrino N; Zhou FX; Zecca M; Defabianis P
Lasers Med Sci; 2017 Aug; 32(6):1423-1428. PubMed ID: 28664389
[TBL] [Abstract][Full Text] [Related]
7. New photobiomodulation protocol prevents oral mucositis in hematopoietic stem cell transplantation recipients-a retrospective study.
Weissheimer C; Curra M; Gregianin LJ; Daudt LE; Wagner VP; Martins MAT; Martins MD
Lasers Med Sci; 2017 Dec; 32(9):2013-2021. PubMed ID: 28840382
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of photobiomodulation therapy in the management of oral mucositis in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled trials.
Shen B; Zhou Y; Wu D; Liu J
Head Neck; 2024 Apr; 46(4):936-950. PubMed ID: 38265122
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness randomized clinical trial on the effect of photobiomodulation therapy for prevention of radiotherapy-induced severe oral mucositis in a Brazilian cancer hospital setting.
Lopes Martins AF; Nogueira TE; Morais MO; de Sousa-Neto SS; Oton-Leite AF; Valadares MC; Aires Freitas NM; Leles CR; Mendonça EF
Support Care Cancer; 2021 Mar; 29(3):1245-1256. PubMed ID: 32621262
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety of photobiomodulation therapy for oral mucositis in hematopoietic cell transplantation patients: a 15-year retrospective study.
Bezinelli LM; Corrêa L; Vogel C; Kutner JM; Ribeiro AF; Hamerschlak N; Eduardo CP; Migliorati CA; Eduardo FP
Support Care Cancer; 2021 Nov; 29(11):6891-6902. PubMed ID: 34021422
[TBL] [Abstract][Full Text] [Related]
11. Most used photobiomodulation dosimetry parameters to treat oral mucositis after preconditioning for hematopoietic stem cell transplantation: systematic review and meta-analysis.
da Silva BM; Prosdócimo ML; Gasparini LR; da Silva BM; de Araujo MR; Amenábar JM
Support Care Cancer; 2022 May; 30(5):3721-3732. PubMed ID: 35013780
[TBL] [Abstract][Full Text] [Related]
12. Effect of photobiomodulation therapy on reducing the chemo-induced oral mucositis severity and on salivary levels of CXCL8/interleukin 8, nitrite, and myeloperoxidase in patients undergoing hematopoietic stem cell transplantation: a randomized clinical trial.
Salvador DRN; Soave DF; Sacono NT; de Castro EF; Silva GBL; E Silva LP; Silva TA; Valadares MC; Mendonça EF; Batista AC
Lasers Med Sci; 2017 Nov; 32(8):1801-1810. PubMed ID: 28664388
[TBL] [Abstract][Full Text] [Related]
13. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial.
Kauark-Fontes E; Migliorati CA; Epstein JB; Treister NS; Alves CGB; Faria KM; Palmier NR; Rodrigues-Oliveira L; de Pauli Paglioni M; Gueiros LAM; da Conceição Vasconcelos KGM; de Castro G; Leme AFP; Lopes MA; Prado-Ribeiro AC; Brandão TB; Santos-Silva AR
Support Care Cancer; 2022 Mar; 30(3):2225-2236. PubMed ID: 34708311
[TBL] [Abstract][Full Text] [Related]
14. Implementation of a light therapy team to administer photobiomodulation therapy: A standardized protocol to prevent and treat oral mucositis in the pediatric hematopoietic stem cell transplant population.
Magee K; Robins J; Staton S; Llaurador G; Stevens AM
Pediatr Blood Cancer; 2024 Jun; 71(6):e30966. PubMed ID: 38556719
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis of the effect of low-level laser therapy (LLLT) on chemotherapy-induced oral mucositis in pediatric and young patients.
He M; Zhang B; Shen N; Wu N; Sun J
Eur J Pediatr; 2018 Jan; 177(1):7-17. PubMed ID: 29128883
[TBL] [Abstract][Full Text] [Related]
16. Photobiomodulation: a promising innovative approach for preventing oral mucositis in patients undergoing hematopoietic stem cell transplantation.
Stocker N; Baltes V; Bellaiche S; Brouillard F; Belmoufid N; Rousseau C; Bonnin A; Van de Wyngaert Z; Ricard L; Banet A; Malard F; Duléry R; Mohty M; Brissot E
Support Care Cancer; 2022 Oct; 30(10):8211-8216. PubMed ID: 35810217
[TBL] [Abstract][Full Text] [Related]
17. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
[TBL] [Abstract][Full Text] [Related]
18. Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update.
Patel P; Robinson PD; Baggott C; Gibson P; Ljungman G; Massey N; Ottaviani G; Phillips R; Revon-Rivière G; Treister N; White M; Cabral S; Dupuis L; Sung L
Eur J Cancer; 2021 Sep; 154():92-101. PubMed ID: 34252760
[TBL] [Abstract][Full Text] [Related]
19. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
[TBL] [Abstract][Full Text] [Related]
20. Oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: clinical outcomes in a context of specialized oral care using low-level laser therapy.
Eduardo Fde P; Bezinelli LM; de Carvalho DL; Lopes RM; Fernandes JF; Brumatti M; Vince CS; de Azambuja AM; Vogel C; Hamerschlak N; Correa L
Pediatr Transplant; 2015 May; 19(3):316-25. PubMed ID: 25677170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
